Rainer Lichtenberger, Stefan Kochanek | GenomeWeb
Cevec Pharmaceuticals this week announced the appointment of Rainer Lichtenberger as CEO, replacing Stefan Kochanek, a founder of the company, who had served as interim CEO.
Lichtenberg most recently was CEO of German biopharmaceutical development company Neuraxo Biotec. He also has held various positions, including vice president of strategic marketing and corporate vice president of business development at the Merckle/ratiopharm group and Merck.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.